3086 Diacylglycerol kinase (DAGK)
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Lipids and lipid-like molecules | 1 | 0.1 | 9.11× | not tested | |
| Homogeneous non-metal compounds | 1 | 0.2 | 4.71× | not tested | |
| Nucleosides, nucleotides, and analogues | 1 | 0.3 | 3.67× | not tested | |
| Homogeneous metal compounds | 1 | 0.5 | 2.07× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03909 | ACP | Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate | 4 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| 78M | (2S)-2,3-DIHYDROXYPROPYL(7Z)-PENTADEC-7-ENOATE | 26 |
| 78N | (2R)-2,3-DIHYDROXYPROPYL(7Z)-PENTADEC-7-ENOATE | 17 |
| 79M | (2R)-2,3-dihydroxypropyl (7Z)-hexadec-7-enoate | 11 |
| NAmetal | SODIUM ION | 11 |
| ZNmetal | ZINC ION | 11 |
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 10 |
| 79N | (2S)-2,3-dihydroxypropyl (7Z)-hexadec-7-enoate | 7 |
| ACP | PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER | 4 |
| CL | CHLORIDE ION | 1 |